Odec 60 Tablet contains Etoricoxib 60 mg, a selective cyclooxygenase-2 (COX-2) inhibitor used primarily for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis. Etoricoxib exerts its therapeutic effects by selectively inhibiting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins responsible for inflammation and pain, while sparing COX-1, which helps maintain gastrointestinal mucosal integrity. This selective action results in effective analgesia with a potentially lower risk of gastrointestinal adverse effects compared to non-selective nonsteroidal anti-inflammatory drugs (NSAIDs). Odec 60 is indicated for short-term and long-term treatment of musculoskeletal disorders and inflammatory conditions where pain relief and improved joint function are desired. The recommended dosage should be individualized based on the patient's condition and response, and it is advised to use the lowest effective dose for the shortest duration necessary to minimize risks. Caution is recommended in patients with cardiovascular disease, renal impairment, or a history of gastrointestinal ulcers. Common side effects may include headache, dizziness, hypertension, and gastrointestinal discomfort. Odec 60 should be used under medical supervision, with regular monitoring for adverse effects and contraindications.